Vanguard Group Inc. increased its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.5% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 641,533 shares of the company’s stock after buying an additional 39,290 shares during the period. Vanguard Group Inc. owned 0.05% of U.S. Physical Therapy worth $41,892,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Sei Investments Co. boosted its stake in shares of U.S. Physical Therapy by 9.0% in the first quarter. Sei Investments Co. now owns 1,954 shares of the company’s stock valued at $128,000 after buying an additional 162 shares during the period. Mason Street Advisors LLC boosted its stake in shares of U.S. Physical Therapy by 7.0% in the first quarter. Mason Street Advisors LLC now owns 2,928 shares of the company’s stock valued at $191,000 after buying an additional 192 shares during the period. MARSHALL WACE ASIA Ltd bought a new stake in shares of U.S. Physical Therapy during the first quarter valued at approximately $226,000. Marshall Wace North America L.P. bought a new stake in shares of U.S. Physical Therapy during the first quarter valued at approximately $226,000. Finally, OppenheimerFunds Inc. boosted its stake in shares of U.S. Physical Therapy by 21.3% in the first quarter. OppenheimerFunds Inc. now owns 3,736 shares of the company’s stock valued at $244,000 after buying an additional 656 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) traded down 0.64% during trading on Friday, reaching $61.70. 52,046 shares of the company’s stock were exchanged. The firm has a market capitalization of $776.25 million, a PE ratio of 39.05 and a beta of 1.06. U.S. Physical Therapy, Inc. has a 52 week low of $51.96 and a 52 week high of $78.00. The company’s 50-day moving average price is $62.62 and its 200 day moving average price is $66.06.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.60 by $0.01. The company had revenue of $104.25 million during the quarter, compared to the consensus estimate of $102.93 million. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. Analysts predict that U.S. Physical Therapy, Inc. will post $2.13 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 8th. Shareholders of record on Monday, August 21st will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date is Thursday, August 17th. U.S. Physical Therapy’s payout ratio is 46.78%.

ILLEGAL ACTIVITY WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/13/u-s-physical-therapy-inc-usph-position-raised-by-vanguard-group-inc.html.

USPH has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “sell” rating to a “buy” rating and set a $72.00 price objective for the company in a research note on Saturday, May 13th. Jefferies Group LLC set a $65.00 price objective on shares of U.S. Physical Therapy and gave the company a “hold” rating in a research note on Friday, August 4th. Barrington Research upgraded shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price objective for the company in a research note on Monday, July 3rd. Finally, Cantor Fitzgerald initiated coverage on shares of U.S. Physical Therapy in a research note on Monday, July 24th. They issued an “overweight” rating and a $72.00 price objective for the company. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. U.S. Physical Therapy currently has a consensus rating of “Hold” and an average target price of $68.50.

In other U.S. Physical Therapy news, Director Bernard A. Harris, Jr. sold 5,000 shares of the company’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $62.00, for a total value of $310,000.00. Following the completion of the sale, the director now directly owns 26,422 shares of the company’s stock, valued at approximately $1,638,164. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.30% of the stock is currently owned by corporate insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.